Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Lisheng Pharmaceutical Group, formerly known as Hebei Aoxing Group Pharmaceutical, is a comprehensive pharmaceutical company based in Shijiazhuang, China. The company specializes in the research, development, manufacturing, and commercialization of traditional Chinese medicines, chemical drugs, and regulated narcotic and psychotropic substances. Following a bankruptcy reorganization completed in 2024, the company was fully acquired by Hebei Ruijitang Chinese Medicine and officially rebranded to its current name in May 2025. Its commercial portfolio features pain management therapies, addiction treatments, and herbal remedies, supported by a large-scale manufacturing facility licensed for narcotic production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北奥星集团.